KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Aug 11, 2016
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Sale
Common Stock
2016-08-09$4.22/sh−1,622$6,845→ 257,123 total
Footnotes (2)
- [F1]Sale of a total of 1,622 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 5,000 shares of restricted stock on August 8, 2016. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 180,687 shares of restricted stock.